DINAMICS OF ARTERIAL STIFFNESS USING CAVI INDEX DEPENDS ON ADDED STATIN TO FIXED COMBINATION ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. (June 2022)
- Record Type:
- Journal Article
- Title:
- DINAMICS OF ARTERIAL STIFFNESS USING CAVI INDEX DEPENDS ON ADDED STATIN TO FIXED COMBINATION ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. (June 2022)
- Main Title:
- DINAMICS OF ARTERIAL STIFFNESS USING CAVI INDEX DEPENDS ON ADDED STATIN TO FIXED COMBINATION ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION
- Authors:
- Rekovets, Oksana
Sirenko, Yuriy
Torbas, Olena
Kushnir, Svitlana
Botsyuk, Yuriy
Primak, Galina - Abstract:
- Abstract : Objective: Aim of this study was to evaluate dynamics of arterial stiffness using cardio-vascular index (CAVI), of the fixed triple combination of valsartan / amlodipine / hydrochlorothiazide and a double fixed combination of valsartan / amlodipine in the treatment of patients with arterial hypertension II-III degree depends on added statin therapy. Design and method: The study included patients with moderate and severe arterial hypertension without diabetes. Patients were divided into 2 groups. The first group (n = 59) was assigned a fixed combination of Val/Amlo/HCT of Val/Amlo plus statins. Patients in the second group (n = 40) received fixed combination Val/Amlo/HCT or Val/Amlo without statins. After 6 months of treatment there was control of therapy. Results: The study included 99 patients with moderate and severe hypertension. The average age of patients 1-st group - 58.05 ± 1.28 (37–75) years, 2-d group – 50, 05 ± 2.30 (24–76) years. Office SBP/DBP at the beginning 1-st group - 162.25 ± 1.53/97.36 ± 1.20 mm Hg and 160.85 ± 2.18/100.30 ± 1.64 mm Hg in 2-nd group. The office heart rate was 70.07 ± 1.14 bpm and 71.90 ± 1.71 bpm respectively. At baseline, 24-h ambulatory SBP/DBP baseline in 1-st group was – 141, 21 ± 1.10 /85, 63 ± 1.11 mm Hg and - 141, 80 ± 1.32 /86, 65 ± 1.33 mm Hg in 2-nd group. Decrease office blood pressure (SBP/DBP) in 1-st group was 35, 69/16, 52 mm Hg (p < 0, 05) and in 2-nd group – 35, 32/21, 77 mm Hg (p < 0, 05). There was increaseAbstract : Objective: Aim of this study was to evaluate dynamics of arterial stiffness using cardio-vascular index (CAVI), of the fixed triple combination of valsartan / amlodipine / hydrochlorothiazide and a double fixed combination of valsartan / amlodipine in the treatment of patients with arterial hypertension II-III degree depends on added statin therapy. Design and method: The study included patients with moderate and severe arterial hypertension without diabetes. Patients were divided into 2 groups. The first group (n = 59) was assigned a fixed combination of Val/Amlo/HCT of Val/Amlo plus statins. Patients in the second group (n = 40) received fixed combination Val/Amlo/HCT or Val/Amlo without statins. After 6 months of treatment there was control of therapy. Results: The study included 99 patients with moderate and severe hypertension. The average age of patients 1-st group - 58.05 ± 1.28 (37–75) years, 2-d group – 50, 05 ± 2.30 (24–76) years. Office SBP/DBP at the beginning 1-st group - 162.25 ± 1.53/97.36 ± 1.20 mm Hg and 160.85 ± 2.18/100.30 ± 1.64 mm Hg in 2-nd group. The office heart rate was 70.07 ± 1.14 bpm and 71.90 ± 1.71 bpm respectively. At baseline, 24-h ambulatory SBP/DBP baseline in 1-st group was – 141, 21 ± 1.10 /85, 63 ± 1.11 mm Hg and - 141, 80 ± 1.32 /86, 65 ± 1.33 mm Hg in 2-nd group. Decrease office blood pressure (SBP/DBP) in 1-st group was 35, 69/16, 52 mm Hg (p < 0, 05) and in 2-nd group – 35, 32/21, 77 mm Hg (p < 0, 05). There was increase the stiffness of the arterial wall in terms of cardio-vascular index CAVI in 2-d group without added statin. CAVI on the right/left site changed from 7.73 ± 0.26/7.62 ± 0.29 units to 8.63 ± 0.32/8.62 ± 0.32 units after treatment (p < 0, 05). Cardio-vascular index (CAVI) in 1-st group with added statin was not changed. CAVI on the right/left site changed from 8.32 ± 0.16/8.33 ± 0.19 units to 8.44 ± 0.16/8.24 ± 0.15 units after treatment (p > 0, 05). Conclusions: The added of statin to fixed combination antihypertensive therapy prevented the progression of arterial stiffness in patients with arterial hypertension. … (more)
- Is Part Of:
- Journal of hypertension. Volume 40(2022)Supplement 1
- Journal:
- Journal of hypertension
- Issue:
- Volume 40(2022)Supplement 1
- Issue Display:
- Volume 40, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 40
- Issue:
- 1
- Issue Sort Value:
- 2022-0040-0001-0000
- Page Start:
- e257
- Page End:
- Publication Date:
- 2022-06
- Subjects:
- Hypertension -- Periodicals
Hypertension -- Periodicals
616.132005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://journals.lww.com/jhypertension/pages/default.aspx ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00004872-000000000-00000 ↗
http://www.jhypertension.com/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/01.hjh.0000838140.16830.9c ↗
- Languages:
- English
- ISSNs:
- 1473-5598
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5004.510000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21969.xml